Pfizer is addressing child safety concerns by designing new packaging for its migraine drug, Nurtec ODT. The recall was prompted by the U.S. Consumer Product Safety Commission due to worries about the drug’s potential danger to children. Pfizer urges consumers to secure the recalled product immediately. The company’s swift action demonstrates its commitment to ensuring […]
The Alzheimer’s Association is leading a campaign with 1,000 individuals who have been diagnosed with or are caring for someone with Alzheimer’s disease. Their goal? To meet with every member of Congress and advocate for Medicare coverage of Leqembi, a promising new class of drugs. This effort involves 535 congressional meetings across the United States, […]
Concerns are rising among eating disorder experts regarding the use of medications like Ozempic and Mounjaro for weight loss purposes. Just as a powerful flame can heat up a room, these diabetes drugs could potentially spark or intensify eating disorders in vulnerable individuals. The worry is that the current trend of utilizing these drugs off-label […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.